Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,607 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Violence, insecurity, and the risk of polio: A systematic analysis.
Guarino K, Voorman A, Gasteen M, Stewart D, Wenger J. Guarino K, et al. Among authors: stewart d. PLoS One. 2017 Oct 11;12(10):e0185577. doi: 10.1371/journal.pone.0185577. eCollection 2017. PLoS One. 2017. PMID: 29020086 Free PMC article.
Has the blood-brain barrier finally been busted?
Stewart DJ. Stewart DJ. Oncologist. 2024 Jun 5:oyae131. doi: 10.1093/oncolo/oyae131. Online ahead of print. Oncologist. 2024. PMID: 38837042 No abstract available.
Consideration of disease penetrance in the selection of secondary findings gene-disease pairs: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
Gordon AS, Lee K, Abul-Husn NS, Amendola LM, Brothers K, Chung WK, Gollob MH, Harrison SM, Hershberger RE, Richards CS, Stewart DR, Martin CL, Miller DT; ACMG Secondary Findings Working Group. Electronic address: documents@acmg.net. Gordon AS, et al. Among authors: stewart dr. Genet Med. 2024 May 30:101142. doi: 10.1016/j.gim.2024.101142. Online ahead of print. Genet Med. 2024. PMID: 38819344 No abstract available.
Canadian cancer trials group LY.17: A randomized phase II study evaluating novel salvage therapy pre-autologous stem cell transplant in relapsed/refractory diffuse large B-cell lymphoma-outcome of rituximab-dose-intensive cyclophosphamide, etoposide, cisplatin (R-DICEP) versus R-GDP.
Stewart DA, Kuruvilla J, Lee D, Dudebout JJ, Chua N, Larouche JF, Baetz T, Shafey M, Abdel-Samad N, Robinson S, Fleury I, Fraser G, Skrabek P, Kukreti V, Kelly J, Hay AE, Shepherd LE, Chen BE, Crump M. Stewart DA, et al. Br J Haematol. 2024 May 27. doi: 10.1111/bjh.19555. Online ahead of print. Br J Haematol. 2024. PMID: 38802107
New Anticancer Drugs: Reliably Assessing "Value" While Addressing High Prices.
Stewart DJ, Bradford JP, Sehdev S, Ramsay T, Navani V, Rawson NSB, Jiang DM, Gotfrit J, Wheatley-Price P, Liu G, Kaplan A, Spadafora S, Goodman SG, Auer RAC, Batist G. Stewart DJ, et al. Curr Oncol. 2024 Apr 28;31(5):2453-2480. doi: 10.3390/curroncol31050184. Curr Oncol. 2024. PMID: 38785465 Free PMC article.
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial.
Parker CC, Clarke NW, Cook AD, Kynaston H, Catton CN, Cross WR, Petersen PM, Persad RA, Saad F, Bower LC, Logue J, Payne H, Forcat S, Goldstein C, Murphy C, Anderson J, Barkati M, Bottomley DM, Branagan J, Choudhury A, Chung PWM, Cogley L, Goh CL, Hoskin P, Khoo V, Malone SC, Masters L, Morris SL, Nabid A, Ong AD, Raman R, Tarver KL, Tree AC, Worlding J, Wylie JP, Zarkar AM, Parulekar WR, Parmar MKB, Sydes MR; RADICALS investigators. Parker CC, et al. Lancet. 2024 Jun 1;403(10442):2405-2415. doi: 10.1016/S0140-6736(24)00548-8. Epub 2024 May 16. Lancet. 2024. PMID: 38763154 Free article. Clinical Trial.
4,607 results